Fitzgerald Kevin Joseph
Alnylam Pharmaceuticals Inc · CSO & EVP
Fitzgerald Kevin Joseph is listed in filings as CSO & EVP at Alnylam Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Mar 4, 2026, including sale activity. Recent filings connect the profile to Alnylam Pharmaceuticals Inc (ALNY). The current snapshot covers public activity from Jan 14, 2026 to Mar 4, 2026. Reported amounts are shown as $72.4K to $7.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.